After being treated with PGZ, there is the increased expression of PPAR-γ and decreased expression of RAGE of HCC cells in a dose-dependent manner, which indicates an association between PGZ administration and the inhibition on the growth and invasion of HCC cells (84). This evidence concerns the gene PPARG and hepatocellular carcinoma.